Into the Crystal Ball: Futures in Retina, Anterior Segment, and Uveitis
NOAO 72nd Annual Symposium
The 72nd Annual Symposium will be held February 9-12, 2023 at the Sheraton New Orleans, 500 Canal Street, New Orleans, LA 70130!
Participants will learn from the brightest ophthalmologists from around the country on the topics of Retina, Anterior Segment, and Uveitis.
Hotel Information Click here to make your reservation at the Sheraton New Orleans Hotel (500 Canal Street, New Orleans, LA). Rooms are $239 per night, and it is recommended that reservations should be made well in advance, as there may be limited room availability after December 1, 2022.
Program Coming Soon!
2023 Confirmed Faculty Speakers
Meghan Berkenstock, MD, Associate Professor of Ophthalmology, Wilmer Eye Institute, Baltimore, MD
Audina Berrocal, MD, Professor of Clinical Ophthalmology, Bascom Palmer Eye Institute, Miami, FL
Jeffery Daigrepont, Senior Vice President, Coker Group, Alpharetta, GA
Eugene de Juan, MD, Jean Kelly Stock Distinguished Chair, University of California San Francisco, San Francisco, CA
Uday Devgan, MD, Devgan Eye Surgery, Los Angeles, CA
Naveen Rao, MD, Lahey Hospital and Medical Center, Burlington, MA
Jennifer Rispo-Maguire, Ophthalmic Administrator, Burlington County Eye Physicians, Philadelphia, PA
Arsham Sheybani, MD, Associate Professor of Ophthalmology, Washington University in St. Louis, St. Louis, MO
Sunil Srivastava, MD, Vitro and Uveitis Specialist, Cole Eye Institute, Cleveland Clinic, Cleveland, OH
Christina Weng, MD, MBA, Associate Professor of Ophthalmology
Thursday, February 9, 6:30-7:30 PM
More information coming soon!
Friday, February 10, 5:30-6:30 PM
More information coming soon!
Check back soon!
Thursday, February 9, 2023, 8:00-11:00 PM
Resident Reunion Night
Join us for a celebration welcoming all of our members and resident/fellow alumni from the past 10 years at Barcadia!
Friday, February 10, 2023, 6:30-8:00 PM
Annual President’s Wine and Cheese Reception
Join us in the Roux Bistro at the Sheraton Hotel for an evening of wine, cheese, and live music with NOAO Board President, Dr. Brandon Davis.
Meghan Berkenstock, MD is an associate professor of ophthalmology at the Johns Hopkins Wilmer Eye Institute. She specializes in ocular inflammatory and infectious diseases, cataract surgery, and comprehensive ophthalmology.
Dr. Berkenstock received her BA from Lehigh University in behavioral neuroscience and history in 2006. In 2011, she received her medical degree from Drexel University. After completing an internship at St. Luke’s University Hospital in Bethlehem, Pennsylvania, she returned to Drexel University for her ophthalmology residency from 2012 to 2015, where she served as chief resident. Thereafter, she completed a uveitis fellowship at UCLA Stein Eye Institute before joining the Wilmer faculty in 2016.
Audina Berrocal, MD is a pediatric retina specialist and world leader in the medical and surgical management of retinopathy of prematurity and pediatric vitreoretinal disorders. Berrocal has been instrumental in the description and management of pediatric retinal disorders. She has advanced the use of fluorescein angiography in pediatric vitreoretinal disorders improving outcomes. She has also taken care of an inner-city neonatal Intensive Care Unit weekly for the past 20 years preventing blindness among the premature. Furthermore, she has been the first surgeon to treat the youngest patient in the United States with the first FDA-approved gene therapy. She has continued this novel, curative surgical treatment among children with Leber’s congenital amaurosis. Not only is she a unique clinician and outstanding surgeon, but she devotes time to teaching and the support of women in the field of ophthalmology and retina. Dr. Berrocal was named to the Ophthalmologist Power List 2022.
Jeffery Daigrepont, senior vice president at Coker Group, specializes in healthcare automation, system integration, cybersecurity, operations, and deployment of enterprise information systems for large integrated delivery networks and medical practices. His specific interests deal with data migration, vendor contracting, strategic IT planning and optimization, security, and compliance.
A popular national speaker, Jeffery is frequently engaged by highly respected organizations across the nation, including many non-profit trade associations and state medical societies. He has co-authored a top-selling book, Complete Guide and Toolkit to Successful EHR Adoption (2011 HIMSS), and is a contributor to The Healthcare Executive’s Guide to ACO Strategy (2015 HCPro).
Eugene de Juan, Jr, MD, renowned retinal surgeon, inventor, and entrepreneur, serves as Vice-Chairman of ForSight Labs, where he participates as an active inventor and advisor in early-stage ophthalmic device opportunities.
Dr. de Juan, Jr., splits his time between ForSight Labs and UCSF. He holds the “Jean Kelly Stock Distinguished Chair” in Ophthalmology. UCSF recruited Dr. de Juan for this special role to augment translation of the many ideas being developed within the academic center. He continues to see patients, operate, and teach at UCSF.
Dr. de Juan, Jr., has participated in the development of a number of ophthalmology’s most exciting new technologies with over 100 products and the founding of nine venture-funded companies including Second Sight, InnoRx, NeoVista, and Retina Labs, in addition to ForSight Labs’ first five “VISION” companies: Transcend Medical, Inc., founded in 2005; VISION2 (acquired by QLT, Inc. in 2007); Nexis Vision, Inc. (formerly ForSight VISION3, Inc.), founded in 2007; ForSight VISION4, Inc., founded in 2009; and ForSight VISION5, Inc., founded in 2010.
Prior to moving to San Francisco, Dr. de Juan, Jr., was a professor of ophthalmology at the University of Southern California and CEO of the Doheny Eye Institute, focusing on innovative techniques for treating blinding retinal disorders through retinal transplantation, macular translocation, robotic surgery, retinal implants, and other new procedures, medicines, and instruments.
Prior to these positions, Dr. de Juan served at the Wilmer Eye Institute at Johns Hopkins University School of Medicine, where he was Co-Director of Vitreoretinal Service, Director of the Microsurgery Advanced Design Laboratory (MADLAB), and Joseph E. Green Professor of Ophthalmology. From 1983 to 1992, he was a member of the medical staff of the Duke University Eye Center, holding joint teaching appointments with the departments of ophthalmology and cell biology.
He is a passionate supporter of ophthalmic education and development and has recently helped establish a chair for Ophthalmic Education at Johns Hopkins University.
Dr. de Juan completed his medical degree and internship training at the University of South Alabama College of Medicine. He served an internship at the University of South Alabama Medical Center followed by a residency at the Wilmer Ophthalmological Institute in Baltimore, MD, and a fellowship in vitreoretinal surgery at Duke University. He holds patents on over sixty medical devices and is responsible for more than 250 academic publications.
Uday Devgan, MD, award-winning and nationally recognized, is a true expert in the field of ocular surgery. Specializing in Cataract, Lens, & LASIK Eye Surgery, Dr. Devgan is known as the Doctors’ Doctor.
“I only remember a few things about kindergarten: playing handball during recess, watching Matilda eat paste, and learning the golden rule. The simple maxim of ‘Do unto others as you would have them do unto you,’ which I learned when I was 5 years old, applies perfectly to the practice of medicine. The golden rule is the cornerstone of my practice and I have found success and satisfaction in applying it to the treatment of my patients.
“My passion is my profession, and I love performing eye surgery to help patients see better. I’m proud of my reputation for excellence, and I take pride in every patient I see and in every surgery I perform. I treat all patients like family. Six years ago, I performed cataract surgery with astigmatism management on my own father (a retired surgeon with high demands of his vision). He was very happy with his new vision, immediately stating, Wow, I wish I had this surgery 5 years ago! I strive to deliver this same high quality to each of my patients, and it’s my test for every surgery I do: What would I do if this patient was my own father, mother, sister, or brother And perhaps more telling is that multiple eye surgeons in Los Angeles area had sent their parents to have cataract surgery by me.”
Naveen K. Rao, MD, is a practicing ophthalmologist at Lahey Hospital and Medical Center in Burlington, Massachusetts. He is also an Assistant Professor of Ophthalmology at Tufts University School of Medicine and Medical Director of Lions VisionGift East in Boston, Massachusetts.
Dr. Rao grew up in Plano, Texas, and attended college at Duke. He majored in chemistry and worked in a research lab investigating ways to inhibit angiogenesis. Outside of class, he volunteered with the campus American Red Cross chapter and had the opportunity to design and run a national college blood drive competition. He attended medical school at Baylor College of Medicine and completed his ophthalmology residency at Casey Eye Institute/Oregon Health & Science University, followed by cornea fellowship training at Tufts and Ophthalmic Consultants of Boston.
Dr. Rao is a member American Society of Cataract and Refractive Surgery (ASCRS) as a member of the Young Eye Surgeons (YES) clinical committee. He co-edits the YES Connect column in EyeWorld magazine, an ASCRS publication.
Arsham Sheybani, MD specializes in glaucoma and complex anterior segment surgery. He is actively involved in research developing devices to improve the safety of glaucoma surgery, pseudoexfoliative glaucoma, malignant glaucoma, and angle-closure glaucoma. Sheybani is an avid surgical teacher of residents and fellows, and he lectures nationally and internationally on novel glaucoma surgeries and complex surgical cases. Growing up in Louisiana has left him with a permanent love for crawfish, so he flies live crawfish to St. Louis for a yearly boil for friends and family.
Sunil Srivastava, MD, is a uveitis and vitreoretinal specialist at the Cole Eye Institute at the Cleveland Clinic. He is the current fellowship director of the vitreoretinal fellowships. He graduated summa cum laude both from Cornell University undergraduate and from SUNY at Buffalo Medical School. He completed his ophthalmology residency at Emory University where he served as chief resident. He pursued and completed two fellowships, one a uveitis/medical retina fellowship at the NEI/NIH and a vitreoretinal surgical fellowship at Duke University. He previously was on faculty at Emory University prior to joining the Cole Eye Institute in 2010. He has been awarded multiple teaching awards both at Emory and at Cole Eye. He is both a Senior Achievement Award recipient from the American Academy of Ophthalmology and a Senior Honor Award from the American Society of Retinal Specialists. He has received multiple Cleveland Clinic Innovations Awards for his work in novel imaging analysis. He has co-authored over 140 publications in peer-reviewed journals and has delivered over 200 lectures at national and international conferences. His current interests include the use of novel imaging in uveitis and retinal diseases, the development of imaging outcome measures in uveitis, and intraoperative imaging in vitreoretinal surgery.
Christina Weng, MD, MBA, is an Associate Professor of Ophthalmology and the Vitreoretinal Diseases & Surgery Fellowship Program Director at the Baylor College of Medicine in Houston, Texas. She has a faculty appointment at the Level 1 trauma center, Ben Taub General Hospital. Dr. Weng was the recipient of the Dan B. Jones Teaching Award in 2016. Dr. Weng graduated cum laude from Northwestern University and then went on to medical school at the University of Michigan where she was elected to the Alpha Omega Alpha (AOA) Medical Society. While in Ann Arbor, she pursued an MBA degree from the University of Michigan-Ross School of Business and graduated with high distinction. Dr. Weng completed her ophthalmology residency at the Wilmer Eye Institute-Johns Hopkins University and surgical retina fellowship at the Bascom Palmer Eye Institute-University of Miami. Dr. Weng is involved with multiple clinical trials; these include the DRCR.net diabetic retinopathy trials and the AGTC Phase 1/2 intravitreal gene therapy study for X-linked retinoschisis. She also leads numerous research studies in her areas of interest: clinical/surgical outcomes, medical economics, healthcare quality metrics, and telemedicine.
“I thought it was one of the MOST WONDERFUL meetings in the world! GREAT information, lots of fun and learning and GREAT attendees.” – Kathleen Digre, Salt Lake City, Utah
“Covers clinically significant subjects, nice group size, good facility, and of course, NOLA.” anonymous, 2016 Symposium
“Excellent conference with three areas of interest, updates and new technologies discussed, 20 hours of CME credit.” -anonymous, 2016 Symposium
“Overall, one of the best meetings as far as content and speakers, a very good learning environment.” -anonymous, 2016 Symposium
“Quality of lectures, ability to personally interact with the experts” – anonymous, 2016 Symposium
“Another phenomenal meeting sponsored by the NOAO!!” – anonymous attendee, 2015 Symposium
Subscribe to our emails or follow us via the social media buttons to the left for all the latest news about our upcoming symposium.
Exhibitors click here for more information and reservation.
Check out our Annual Symposium for general information or our FAQs page to find out more information about NOAO, benefits, the process to become a member, annual symposia, quarterly dinners, and more.
Member feedback greatly aids the formation of this world-class educational meeting. If you have any suggestions for topics and/or speakers, please contact us as soon as possible.